For IPSS, there was no marked change in the trend of effective size compared with placebo, however, the effective size of difference compared with placebo showed a decreasing trend ( Fig 3B ).
← all excerpts
Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis.
1
—
—